IL4 and asthma: The same study suggested that TLR3 systemically modulated disease development in a rat asthma model by reducing serum IgE release via IL4 down-regulation, which may provide a vital clue for further research in asthma pathogenesis and suggest a new target for asthma treatment (Meng et al., 2011).